Seres Therapeutics, Inc. (MCRB)
2.09
-0.04
(-1.88%)
USD |
NASDAQ |
Oct 23, 16:00
2.10
+0.01
(+0.48%)
After-Hours: 20:00
Seres Therapeutics Market Cap : 20.54M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 20.54M |
| October 22, 2026 | 20.93M |
| October 21, 2026 | 22.60M |
| October 20, 2026 | 22.70M |
| October 19, 2026 | 23.78M |
| October 16, 2026 | 24.18M |
| October 15, 2026 | 24.86M |
| October 14, 2026 | 23.78M |
| October 13, 2026 | 24.86M |
| October 12, 2026 | 26.34M |
| October 09, 2026 | 26.63M |
| October 08, 2026 | 25.85M |
| October 07, 2026 | 26.73M |
| October 06, 2026 | 28.50M |
| October 05, 2026 | 28.01M |
| October 02, 2026 | 28.89M |
| October 01, 2026 | 28.79M |
| September 30, 2026 | 32.92M |
| September 29, 2026 | 34.20M |
| September 28, 2026 | 34.59M |
| September 25, 2026 | 34.59M |
| September 24, 2026 | 35.58M |
| September 23, 2026 | 37.25M |
| September 22, 2026 | 39.51M |
| September 21, 2026 | 40.00M |
| Date | Value |
|---|---|
| September 18, 2026 | 39.31M |
| September 17, 2026 | 40.29M |
| September 16, 2026 | 41.37M |
| September 15, 2026 | 45.21M |
| September 14, 2026 | 46.48M |
| September 11, 2026 | 49.24M |
| September 10, 2026 | 50.12M |
| September 09, 2026 | 51.89M |
| September 08, 2026 | 54.64M |
| September 04, 2026 | 56.21M |
| September 03, 2026 | 55.43M |
| September 02, 2026 | 54.44M |
| September 01, 2026 | 50.91M |
| August 31, 2026 | 48.25M |
| August 28, 2026 | 50.22M |
| August 27, 2026 | 48.65M |
| August 26, 2026 | 46.78M |
| August 25, 2026 | 49.14M |
| August 24, 2026 | 45.80M |
| August 21, 2026 | 44.81M |
| August 20, 2026 | 44.91M |
| August 19, 2026 | 45.99M |
| August 18, 2026 | 42.65M |
| August 17, 2026 | 44.32M |
| August 14, 2026 | 44.62M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| PS Ratio | 10.45 |
| PEG Ratio | -0.0041 |
| Price to Book Value | 0.5948 |
| Price | 2.09 |
| Earnings Yield | -109.0% |
| PEGY Ratio | -0.0041 |